Naia Relief Announces Conditional Approval for Listing on the TSX Venture Exchange and Commencement of Trading
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2026) - Naia Relief Inc. (the "Company" or "Naia Relief") is pleased to announce that it has received conditional approval of the TSX Venture Exchange ("TSXV") to list its common shares on the TSXV. The Company's common shares will commence trading on the TSXV under the symbol "NAIA", effective market open on September 15, 2026. In addition, further to the Company's press release of September 8, 2026, an a
2026-09-11 7:00 AM EDT | Naia Relief Inc.
Psyched Wellness Announces Secured Term Loan
Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregat
Cannabis, Santé, Psychédéliques, Producteurs de cannabis
2026-09-10 4:15 PM EDT | Psyched Wellness Ltd.
DiagnosTear Announces Positive Final Results from Clinical Study Demonstrating Strong Diagnostic Performance of TeaRx(TM) Red Eye for Detecting Total Tear IgE as a Biomarker for Allergic conjunctivitis
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), an innovator in point-of-care ocular diagnostics, is pleased to announce positive final results from its clinical study conducted with AlyaTec for TeaRx™ Red Eye further to the Company's press releases dated December 2, 2025, February 26, 2026, and July 9, 2026. The final results were obtained and analysed from 93 tear sa
2026-09-10 8:30 AM EDT | DiagnosTear Technologies Inc.
Rhelion Life Sciences Announces Filament Health is Planning a Stability Program for IBEX011, Its Naturally Derived Ibogaine Drug Candidate
Toronto, Ontario--(Newsfile Corp. - September 10, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic se
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-09-10 7:55 AM EDT | Rhelion Life Sciences Corp.
MD Hyperbaric Appoints Renowned Hyperbaric Researcher Dr. Amir Hadanny as Chief Medical Officer
New York, New York--(Newsfile Corp. - September 9, 2026) - MD Hyperbaric, one of the fastest-growing hyperbaric oxygen therapy (HBOT) networks in the United States, announced the appointment of Amir Hadanny, MD, as Chief Medical Officer. Dr. Hadanny is a neurosurgeon and hyperbaric physician and one of the most published clinical researchers in hyperbaric medicine, with more than 80 peer-reviewed publications. In this role,
Soins de santé et hôpitaux, Santé
2026-09-09 9:00 AM EDT | MD Hyperbaric
LevelJump Announces Management Change
Toronto, Ontario--(Newsfile Corp. - September 9, 2026) - LevelJump Healthcare Corp. - (TSXV: JUMP) ("LevelJump" or the "Company") wishes to announce the appointment of Gus Patel as the Company's interim Chief Financial Officer effective September 1, 2026, replacing Robert Landau. Gus Patel is a finance executive, tax practitioner and licensed public accountant with more than 15 years of experience across public companies, private enterprises and professiona
Soins de santé et hôpitaux, Santé
2026-09-09 8:37 AM EDT | LevelJump Healthcare Corp.
QScreen AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - September 9, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, intelligence platform for clinical and occupational health applications, is pleased to announce the closing of the final tranche of its previously announced non-brokered private placement. The Company is pleased to announce that it has completed the final tranche of its previously announced non-
2026-09-09 6:15 AM EDT | QScreen AI Inc.
WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer
WELL has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026. Ms. Sutherland brings more than 20 years of senior financial leadership experience, including CFO roles at Staples Canada, Enercare Inc., KEYreit, and United Purchasing Group of Canada (Yum! Brands). Ms. Sutherland has served on the Board of WELL's subsidiary, WELLSTAR, over the past year and brings direct knowledge of the Company's strategy, governance an
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-09-09 6:00 AM EDT | WELL Health Technologies Corp.
Naia Relief Announces Closing of Reverse Takeover Transaction
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2026) - Naia Relief Inc. (formerly, 1329308 B.C. Ltd.) (the "Company") announces that, further to its press releases dated October 3, 2025, July 6, 2026, July 30, 2026, August 19, 2026 and September 1, 2026, it has completed its previously announced reverse takeover transaction (the "Transaction") pursuant to which the Company acquired all of the issued and outstanding securities of Relief AI Inc. ("Relief AI").
2026-09-08 5:40 PM EDT | Naia Relief Inc.
Nasdaq Shareholder Requirements Just Verified By Adia Med
Winter Park, Florida--(Newsfile Corp. - September 8, 2026) - Nasdaq requires companies seeking an initial listing on the Nasdaq Capital Market to have a sufficiently broad public shareholder base. That distribution test includes: At least 300 round-lot holders; A round-lot holder generally meaning a shareholder holding at least 100 unrestricted shares; and Adia Med has just verified that it currently has 361 round-lot holders, or
Soins de santé et hôpitaux, Santé
2026-09-08 8:00 AM EDT | Adia Med Inc.
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes Shipment of PEX010 to Australia for University of Melbourne Trial of Psilocybin-Assisted Physiotherapy in Functional Neurological Disorder
Filament Health's patented, naturally derived psilocybin drug candidate PEX010 has been shipped to Austin Health in Melbourne for PSI-PHY, an investigator initiated pilot trial of psilocybin-assisted physiotherapy in refractory motor functional neurological disorder, sponsored by The University of Melbourne and funded by the Australian Government's Medical Research Future Fund The study is the first trial of PEX010 in a movement disorder and, to the Company's kno
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-09-08 7:52 AM EDT | Rhelion Life Sciences Corp.
Altrova Health Signs Exclusive U.S. Distribution Agreement to Launch Its Detection and Wellness Portfolio Across the United States
Toronto, Ontario--(Newsfile Corp. - September 8, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") is pleased to announce that it has entered into an exclusive distribution agreement (the "Distribution Agreement") with Reliability Funding LLC ("Reliability" or the "Distributor") appointing Reliability as the Company's exclusive sales agent and distributor for its product portfolio across the entire United S
2026-09-08 7:07 AM EDT | Altrova Health Inc.
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Orga
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-09-08 6:30 AM EDT | WELL Health Technologies Corp.
Custom Health Completes Acquisition of Spencer Health Solutions, Bringing In-Home Medication Dispensing Technology Fully In-House
Effective September 4, 2026, Custom Health has completed its previously announced acquisition of Spencer Health Solutions, developer of the spencer® smart medication dispenser and in-home monitoring platform, giving the Company full ownership of the spencer® technology, intellectual property, and product roadmap. Spencer now operates as a wholly owned subsidiary of Custom Health, eliminating third-party support, infrastructure, and device costs previously incu
Technologies, Pharmaceutique, Santé
2026-09-08 6:00 AM EDT | Custom Health Holdings Inc.
Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
Montreal, Quebec--(Newsfile Corp. - September 8, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, is pleased to provide a letter to shareholders from President and Chief Executive Officer Dr. Amie Phinney outlining recent corporate progress, strategic priorities and the Company'
Biotechnologies, Pharmaceutique, Santé
2026-09-08 3:15 AM EDT | Defence Therapeutics Inc.
Defence Therapeutics Provides Updates on Sharing Agreement
Montreal, Quebec--(Newsfile Corp. - September 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to provide an update on its sharing agreement dated March 6, 2026 (the "Sharing Agreement") with Sorbie Bornholm LP ("SBLP") previously described in the Company's news releases of March 9 and February 27, 202
Biotechnologies, Pharmaceutique, Santé
2026-09-04 6:00 PM EDT | Defence Therapeutics Inc.
First Towers & Fiber Corp. Delivers First Cash Flow from New 200 KM Fiber Network, Eyes Expansion with Client
Toronto, Ontario--(Newsfile Corp. - September 4, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, today announced a series of operational and financial milestones that mark a significant step forward in the Company's transition into a recurring revenue-generating telecommunications infrastructure business. First Cash Lease Payment Col
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-09-04 9:05 AM EDT | Akanda Corp
Edison Issues Report on Percheron Therapeutics (PER)
London, United Kingdom--(Newsfile Corp. - September 4, 2026) - Edison issues report on Percheron Therapeutics (ASX: PER) Percheron's clinical strategy has taken an important turn with the announcement of an investigator-sponsored exploratory study of HMBD-002 in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), led by Vanderbilt Health. Percheron's contribution will be limited to providing the study drug, a financial grant and advisory support. Following the announcement
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-09-04 5:00 AM EDT | Edison Group
Tersis Technologies Engages DIFFRNT Developments to Lead Web Development and Digital Infrastructure
Miami, Florida--(Newsfile Corp. - September 3, 2026) - Tersis Technologies, Inc. (OTCID: TERS), a clean technology company advancing waste-to-value and circular infrastructure solutions, today announced that it has engaged DIFFRNT Developments to lead the development, hosting, and ongoing management of the Company's web platforms and digital infrastructure. The engagement brings Tersis's website development, hosting, maintenance, cybersecurity, technical search optimization, CRM integra
Agriculture, Énergie, Énergies de substitution, Santé
2026-09-03 1:01 PM EDT | Tersis Technologies Inc.
AVANT and Health In A Box Launch Physician-Led Preventive Health Programs For Club Members
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - AVANT, the premium private fitness and wellness club, and Health In A Box® today announced a partnership that brings physician-led preventive health programs to AVANT members beginning in mid-September. Members receive biomarker testing, clinical interpretation, and a personalized health action plan built with a clinical team of physicians and naturopathic doctors. Clinical review and follow-up are delivered virtually. AVANT'
Soins de santé et hôpitaux, Santé
2026-09-03 8:00 AM EDT | Health In A Box Inc.